Vitamin A controls the presence of RORγ+ innate lymphoid cells and lymphoid tissue in the small intestine

Journal of Immunology

Volumn 196, Issue 12, 2016, Pages 5148-5155

  Goverse, Gera ^a   Labao Almeida, Carlos ^b   Ferreira, Manuela ^b   Molenaar, Rosalie ^a   Wahlen, Sigrid ^a   Konijn, Tanja ^a   Koning, Jasper ^a   Veiga Fernandes, Henrique ^b   Mebius, Reina E ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; INTERLEUKIN 22; RETINOL; ROR GAMMA PROTEIN; UNCLASSIFIED DRUG; LY ANTIGEN; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; NCR1 PROTEIN, MOUSE; RETINOIC ACID; RETINOID RELATED ORPHAN RECEPTOR GAMMA;

ANIMAL EXPERIMENT; ARTICLE; CELL COUNT; CELL DIFFERENTIATION; CELL POPULATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; INTRACELLULAR SIGNALING; LYMPHOID CELL; LYMPHOID TISSUE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMALL INTESTINE; ANIMAL; CYTOLOGY; DEFICIENCY; DRUG EFFECTS; GENETICS; IMMUNOLOGY; INNATE IMMUNITY; LYMPHOCYTE SUBPOPULATION; METABOLISM; RETINOL DEFICIENCY; SIGNAL TRANSDUCTION;

ANIMALS; ANTIGENS, LY; IMMUNITY, INNATE; INTESTINE, SMALL; LYMPHOCYTE SUBSETS; LYMPHOID TISSUE; MICE; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; NUCLEAR RECEPTOR SUBFAMILY 1, GROUP F, MEMBER 3; SIGNAL TRANSDUCTION; TRETINOIN; VITAMIN A; VITAMIN A DEFICIENCY;

EID: 84974801198     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1501106     Document Type: Article

References (37)

1. Spits, H., and T. Cupedo. 2012. Innate lymphoid cells: emerging insights in development, lineage relationships, and function. Annu. Rev. Immunol. 30: 647-675.
2. Spencer, S. P., and Y. Belkaid. 2012. Dietary and commensal derived nutrients: shaping mucosal and systemic immunity. Curr. Opin. Immunol. 24: 379-384.
3. Walker, J. A., J. L. Barlow, and A. N. J. McKenzie. 2013. Innate lymphoid cells-how did we miss them? Nat. Rev. Immunol. 13: 75-87.
4. Mjösberg, J., J. Bernink, C. Peters, and H. Spits. 2012. Transcriptional control of innate lymphoid cells. Eur. J. Immunol. 42: 1916-1923.
5. Spits, H., and J. P. Di Santo. 2011. The expanding family of innate lymphoid cells: regulators and effectors of immunity and tissue remodeling. Nat. Immunol. 12: 21-27.
6. Spits, H., D. Artis, M. Colonna, A. Diefenbach, J. P. Di Santo, G. Eberl, S. Koyasu, R. M. Locksley, A. N. J. McKenzie, R. E. Mebius, et al. 2013. Innate lymphoid cells-A proposal for uniform nomenclature. Nat. Rev. Immunol. 13: 145-149.
7. Vonarbourg, C., A. Mortha, V. L. Bui, P. P. Hernandez, E. A. Kiss, T. Hoyler, M. Flach, B. Bengsch, R. Thimme, C. Hölscher, et al. 2010. Regulated expression of nuclear receptor RORgt confers distinct functional fates to NK cell receptor-expressing RORgt+ innate lymphocytes. Immunity 33: 736-751.
8. Walker, J. A., and A. N. J. McKenzie. 2013. Development and function of group 2 innate lymphoid cells. Curr. Opin. Immunol. 25: 148-155.
9. Mebius, R. E., P. Rennert, and I. L. Weissman. 1997. Developing lymph nodes collect CD4+CD32 LTb+ cells that can differentiate to APC, NK cells, and follicular cells but not T or B cells. Immunity 7: 493-504.
10. Cella, M., A. Fuchs, W. Vermi, F. Facchetti, K. Otero, J. K. M. Lennerz, J. M. Doherty, J. C. Mills, and M. Colonna. 2009. A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature 457: 722-725.
11. Kiss, E. A., C. Vonarbourg, S. Kopfmann, E. Hobeika, D. Finke, C. Esser, and A. Diefenbach. 2011. Natural aryl hydrocarbon receptor ligands control organogenesis of intestinal lymphoid follicles. Science 334: 1561-1565.
12. Qiu, J., J. J. Heller, X. Guo, Z. M. E. Chen, K. Fish, Y. X. Fu, and L. Zhou. 2012. The aryl hydrocarbon receptor regulates gut immunity through modulation of innate lymphoid cells. Immunity 36: 92-104.
13. Qiu, J., X. Guo, Z. M. E. Chen, L. He, G. F. Sonnenberg, D. Artis, Y. X. Fu, and L. Zhou. 2013. Group 3 innate lymphoid cells inhibit T-cell-mediated intestinal inflammation through aryl hydrocarbon receptor signaling and regulation of microflora. Immunity 39: 386-399.
14. Mielke, L. A., S. A. Jones, M. Raverdeau, R. Higgs, A. Stefanska, J. R. Groom, A. Misiak, L. S. Dungan, C. E. Sutton, G. Streubel, et al. 2013. Retinoic acid expression associates with enhanced IL-22 production by gd T cells and innate lymphoid cells and attenuation of intestinal inflammation. J. Exp. Med. 210: 1117-1124.
15. Spencer, S. P., C. Wilhelm, Q. Yang, J. A. Hall, N. Bouladoux, A. Boyd, T. B. Nutman, J. F. Urban, Jr., J. Wang, T. R. Ramalingam, et al. 2014. Adaptation of innate lymphoid cells to a micronutrient deficiency promotes type 2 barrier immunity. Science 343: 432-437.
16. van de Pavert, S. A., M. Ferreira, R. G. Domingues, H. Ribeiro, R. Molenaar, L. Moreira-Santos, F. F. Almeida, S. Ibiza, I. Barbosa, G. Goverse, et al. 2014. Maternal retinoids control type 3 innate lymphoid cells and set the offspring immunity. Nature 508: 123-127.
17. Germain, P., J. Iyer, C. Zechel, and H. Gronemeyer. 2002. Co-regulator recruitment and the mechanism of retinoic acid receptor synergy. Nature 415: 187-192.
18. Iwata, M., A. Hirakiyama, Y. Eshima, H. Kagechika, C. Kato, and S. Y. Song. 2004. Retinoic acid imprints gut-homing specificity on T cells. Immunity 21: 527-538.
19. Wendling, O., C. Dennefeld, P. Chambon, and M. Mark. 2000. Retinoid signaling is essential for patterning the endoderm of the third and fourth pharyngeal arches. Development 127: 1553-1562.
20. Eberl, G., and D. R. Littman. 2004. Thymic origin of intestinal ab T cells revealed by fate mapping of RORgt+ cells. Science 305: 248-251.
21. Rosselot, C., L. Spraggon, I. Chia, E. Batourina, P. Riccio, B. Lu, K. Niederreither, P. Dolle, G. Duester, P. Chambon, et al. 2010. Non-cellautonomous retinoid signaling is crucial for renal development. Development 137: 283-292.
22. Sonnenberg, G. F., L. A. Fouser, and D. Artis. 2011. Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22. Nat. Immunol. 12: 383-390.
23. Molenaar, R., M. Knippenberg, G. Goverse, B. J. Olivier, A. F. de Vos, T. OToole, and R. E. Mebius. 2011. Expression of retinaldehyde dehydrogenase enzymes in mucosal dendritic cells and gut-draining lymph node stromal cells is controlled by dietary vitamin A. J. Immunol. 186: 1934-1942.
24. van de Pavert, S. A., and R. E. Mebius. 2010. New insights into the development of lymphoid tissues. Nat. Rev. Immunol. 10: 664-674.
25. Kanamori, Y., K. Ishimaru, M. Nanno, K. Maki, K. Ikuta, H. Nariuchi, and H. Ishikawa. 1996. Identification of novel lymphoid tissues in murine intestinal mucosa where clusters of c-kit+ IL-7R+ Thy1+ lympho-hemopoietic progenitors develop. J. Exp. Med. 184: 1449-1459.
26. Pabst, O., H. Herbrand, M. Friedrichsen, S. Velaga, M. Dorsch, G. Berhardt, T. Worbs, A. J. Macpherson, and R. Förster. 2006. Adaptation of solitary intestinal lymphoid tissue in response to microbiota and chemokine receptor CCR7 signaling. J. Immunol. 177: 6824-6832.
27. Rajaii, F., Z. T. Bitzer, Q. Xu, and S. Sockanathan. 2008. Expression of the dominant negative retinoid receptor, RAR403, alters telencephalic progenitor proliferation, survival, and cell fate specification. Dev. Biol. 316: 371-382.
28. Martin, J. C. J., G. Bériou, M. Heslan, C. Chauvin, L. Utriainen, A. Aumeunier, C. L. Scott, A. Mowat, V. Cerovic, S. A. Houston, et al. 2014. Interleukin-22 binding protein (IL-22BP) is constitutively expressed by a subset of conventional dendritic cells and is strongly induced by retinoic acid. Mucosal Immunol. 7: 101-113.
29. Jones, B. C., N. J. Logsdon, and M. R. Walter. 2008. Structure of IL-22 bound to its high-Affinity IL-22R1 chain. Structure 16: 1333-1344.
30. Bishop, J. L., M. E. Roberts, J. L. Beer, M. Huang, M. K. Chehal, X. Fan, L. A. Fouser, H. L. Ma, J. T. Bacani, and K. W. Harder. 2014. Lyn activity protects mice from DSS colitis and regulates the production of IL-22 from innate lymphoid cells. Mucosal Immunol. 7: 405-416.
31. Huber, S., N. Gagliani, L. A. Zenewicz, F. J. Huber, L. Bosurgi, B. Hu, M. Hedl, W. Zhang, W. OConnor, Jr., A. J. Murphy, et al. 2012. IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestine. Nature 491: 259-263.
32. Kirchberger, S., D. J. Royston, O. Boulard, E. Thornton, F. Franchini, R. L. Szabady, O. Harrison, and F. Powrie. 2013. Innate lymphoid cells sustain colon cancer through production of interleukin-22 in a mouse model. J. Exp. Med. 210: 917-931.
33. Manta, C., E. Heupel, K. Radulovic, V. Rossini, N. Garbi, C. U. Riedel, and J. H. Niess. 2013. CX3CR1+ macrophages support IL-22 production by innate lymphoid cells during infection with Citrobacter rodentium. Mucosal Immunol. 6: 177-188.
34. Longman, R. S., G. E. Diehl, D. A. Victorio, J. R. Huh, C. Galan, E. R. Miraldi, A. Swaminath, R. Bonneau, E. J. Scherl, and D. R. Littman. 2014. CX3CR1+ mononuclear phagocytes support colitis-Associated innate lymphoid cell production of IL-22. J. Exp. Med. 211: 1571-1583.
35. Buonocore, S., P. P. Ahern, H. H. Uhlig, I. I. Ivanov, D. R. Littman, K. J. Maloy, and F. Powrie. 2010. Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. Nature 464: 1371-1375.
36. Duerr, R. H., K. D. Taylor, S. R. Brant, J. D. Rioux, M. S. Silverberg, M. J. Daly, A. H. Steinhart, C. Abraham, M. Regueiro, A. Griffiths, et al. 2006. A genomewide association study identifies IL23R as an inflammatory bowel disease gene. Science 314: 1461-1463.
37. Zwiers, A., L. Kraal, T. C. van de Pouw Kraan, T. Wurdinger, G. Bouma, and G. Kraal. 2012. Cutting edge: A variant of the IL-23R gene associated with inflammatory bowel disease induces loss of microRNA regulation and enhanced protein production. J. Immunol. 188: 1573-1577.